Most of the cases of monkeypox occurring following single dose of the MVA-BN vaccine occur within 14 days.
Positive association seen for children with and without eczema; CDC is not changing current vaccine recommendations.
The quadrivalent modRNA influenza vaccine candidate uses mRNA technology, which requires only the genetic sequence of the virus.
Most individuals (82.8%) reported a local reaction after a COVID-19 booster or third dose, and 67.9% reported at least one systemic symptom.
A State Disaster Emergency was declared in New York due to evidence of circulating poliovirus.
GBS6 is an investigational maternal vaccine designed to protect against the 6 most prominent GBS serotypes.
The AAP recommends annual vaccination against influenza for all children without medical contraindications, starting at age 6 months.
In general, routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications and should be completed by the end of October.
The FDA has authorized the bivalent Moderna and Pfizer-BioNTech COVID-19 Vaccines as a single booster dose at least 2 months following the primary or booster vaccination.
Researchers answer 5 questions about the new Omicron booster shots that may be FDA-approved for use this fall.
The FDA has expanded the EUA for the Novavax COVID-19 Vaccine, Adjuvanted to include adolescents 12 to 17 years of age to prevent COVID-19.
Divided attention and positive memory reframing are feasible and may reduce vaccine-related distress in children
Updated vaccine targeted to the Omicron variant is expected to have “important role” in protecting people from COVID-19 this winter
Discovery of poliovirus in sewage samples suggests there is already community transmission of the virus.
Under the EUA, Jynneos can be administered either intradermally for individuals aged ≥18 years or subcutaneously for individuals aged <18 years.
An individual is considered fully vaccinated about 2 weeks after the second dose of Jynneos and 4 weeks after receiving ACAM2000.
Adults at risk of hepatitis A and hepatitis B have multi-dose vaccinations available, but complete and timely vaccination adherence rates are low. What can be done to encourage more vaccine adherence?
The Novavax COVID-19 Vaccine, Adjuvanted is administered intramuscularly as a 2-dose primary series (0.5mL each), separated by 3 weeks.
The approval was based on data from a phase 3 trial which included 2260 adolescents 12 to 15 years of age enrolled in the United States.
Two Omicron-adapted Pfizer-BioNTech COVID-19 vaccine candidates elicited strong immune responses vs the current COVID-19 vaccine.